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Antenatal depression and anxiety are significant public health problems. Birth and neonatal 
outcomes suffer as a result of maternal depression and anxiety during pregnancy. As such, 
effectively treating depression and anxiety in the expectant mother is imperative to the overall 
health of mother and child. Psychopharmaceuticals are effective in alleviating depressed and 
anxious symptoms, but the evidence of the safety of their use during pregnancy is inconclusive. 
Furthermore, pregnant women themselves express the desire for non-psychopharmaceutical 
options when deciding how to manage their depression or anxiety. Mindfulness-based 
interventions show promise as a non-invasive, non-pharmaceutical option for managing negative 
affective states. To help predict the likelihood of a successful adoption of mindfulness-based 
interventions, midwives’ perspectives on using mindfulness in clinical settings with their 
depressed or anxious patients were investigated. Results indicated favorable attitudes towards 
using mindfulness, along with various barriers that may prevent the adoption of mindfulness in 
clinical settings. 
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1.0  INTRODUCTION 
OUTCOMES 
less epidemiological research has been done on antenatal anxiety than on 
antenat
1.1 ANTENATAL DEPRESSION AND ANXIETY: PREVALENCE AND 
Reported prevalence rates of antenatal depression and anxiety vary. As low as nine percent and 
as high as 25 percent of all pregnant women are diagnosed with depression at some point during 
their pregnancy. One study reported antenatal depression at an elevated prevalence rate of 37.1 
percent (Lee et al., 2007). Risk rates for antenatal depression reflect a similar range, with women 
of child-bearing age having as low as a 10 percent risk and as high as a 25 percent risk for 
developing a depressive disorder during pregnancy (Wisner et al., 1999). Prevalence research on 
antenatal anxiety is sparse, but evidence also suggests a wide range of prevalence rates, with as 
low as 6.6 percent (Andersson et al., 2003) of all pregnant women suffering from anxiety during 
pregnancy and has high as 54 percent meeting the clinical criteria for anxiety (Lee et al., 2007). 
It should be noted that 
al depression.   
A host of negative birth outcomes are associated with antenatal depression and anxiety. 
Infants born from mothers with depression or anxiety are at increased risk for being born low 
birth weight; infants weighing less than 2,500 grams (or 5 lbs., 8 oz.) are classified as low birth 
weight (Hamilton et al., 2009). Low birth weight is a very serious adverse birth outcome that can 
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lead to neonatal complications, developmental delays, and infant mortality (Goldenberg & 
Culhane, 2007). In a study of chronic prenatal depression and neonatal outcomes, infants whose 
mothers were chronically depressed during pregnancy were of lower gestational age and lower 
birth weight than infants born to non-depressed mothers (Field et al. 2008).  Similarly, a study 
that examined the association between psychological stress or distress and low birth weight 
found a significant association between maternal psychological distress in the second and third 
trimest
rmones delivered earlier than pregnant women with low 
levels o
ers of pregnancy and low birth weight infants (Rondo et al., 2003).  
Another undesirable birth outcome associated with antenatal maternal depression and 
anxiety is preterm birth; preterm birth is any birth that occurs at less than 37 weeks of gestational 
age (Goldenberg et al., 2008). A large percentage (75%) of perinatal mortalities is attributed to 
preterm birth, and greater than 50 percent of long-term infant morbidity results from preterm 
birth (McCormick, 1985). Preterm birth is also associated with low birth weight, which as 
previously mentioned, is a birth outcome that can have dire consequences for the newborn. Li et 
al. (2009) conducted a prospective cohort study to determine the impact of antenatal depression 
on the risk of preterm delivery. Women experiencing depression during pregnancy were twice as 
likely to deliver preterm. A dose-response relationship between levels of depression and risk for 
preterm delivery was also reported: the risk for preterm delivery increased with higher levels of 
depression. Mancuso et al. (2004) found that women with higher levels of anxiety during 
pregnancy and higher levels of stress ho
f anxiety and stress hormones.  
One proposed causal pathway for these negative birth outcomes is the effect stress, 
anxiety, and depression have on the maternal immune response. Cytokines—such as Interleukin 
6—are found to be at elevated levels in the serum of pregnant women experiencing negative 
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psychosocial states (Coussons-Read et al., 2005; Coussons-Read et al., 2007). Subsequent 
adverse birth outcomes similar to those reported in the literature on outcomes associated with 
antenatal depression and anxiety have been observed in women with elevated IL-6; these 
outcomes include preterm birth, miscarriage, and preeclampsia (Cobo et al., 2009; Hattori et al., 
2007; Jonsson et al., 2007). There is also evidence that antenatal elevated levels of IL-6 are 
associated with the development of autism and schizophrenia in offspring in animal studies 
(Smith 
n unplanned cesareans increases the risk of maternal and 
fetal m
et al., 2007). 
Maternal mood can also negatively impact obstetric outcomes. Women with depressive 
symptoms during pregnancy are more likely to receive epidural analgesia, and operative 
deliveries—caesareans or instrumental vaginal deliveries—are more likely to occur among 
depressed women as well (Chung et al., 2001). Saunders et al. (2006) found similar obstetric 
events associated with maternal stress and a possible relationship between analgesia receipt and 
unplanned cesarean, suggesting that analgesia administration may increase the need for an 
unplanned cesarean. Resorting to unplanned cesareans is not an ideal obstetric intervention: 
failed progression of labor that results i
orbidity (Murphy et al., 2001).   
Neonatal outcomes suffer from the presence of maternal depression and/or anxiety during 
pregnancy. Chung et al., (2001) found that infants born to mothers who presented with 
depressive symptoms during their pregnancy were at increased risk of being admitted to the 
neonatal intensive care unit. Furthermore, infants of antenatally depressed mothers have been 
shown to present with inferior performance on standardized neurobehavioral assessments (Lundy 
et al., 1999; Field et al., 2004). One explanation for the infants’ sub par performance—especially 
behaviors associated with depression—is the apparent biochemical mimicry that occurs between 
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the mother and infant. The biochemical composition of infants of depressed women mirrors that 
of the mother: infants present with higher cortisol levels and lower dopamine and serotonin 
chemic
nd varied, ranging from physical 
problem
 with the mother, disrupting 
the bon
als, much like their mothers (Field et al., 2004).  
Depressive and anxious/stressed symptoms during pregnancy are also associated with 
excessive crying in infants born to depressed or anxious women (van der Wal et al., 2007). 
Respiratory distress in infants of depressed or anxious mothers may be another complication 
associated with negative maternal affective states, but the study that found this complication did 
not use a control group of pregnant women free from depression or anxiety to compare to the 
pregnant women with depression or anxiety (Mirsi et al., 2004). Untreated antenatal depression 
may also disrupt the fetus’s heart rate. Allister et al. (2001) found elevated heart rate levels in 
fetuses of depressed women. Thus, the potential adverse neonatal outcomes associated with 
depression or anxiety during pregnancy are numerous a
s to alteration in the infants physiological make-up. 
In addition to adverse birth, obstetric, and neonatal outcomes, antenatal maternal 
depression and anxiety puts women at a greater risk for developing post-partum depression 
(Milgrom et al., 2008). Post-partum depression has been reported to have an array of negative 
consequences on the mother-infant dyad. When interacting with their infants, depressed mothers 
exhibit behaviors that cumulatively result in decreased face-to-face mother-infant interaction. 
Less positive affect, less activity, less responsiveness, more discontented facial expressions, and 
engaging in less game-playing have all been observed in depressed mothers’ interaction with 
their infants (Field, 1985). This in turn affects the infant’s interaction
ding that normally occurs between the mother-infant dyad.   
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Post-partum depression can also have numerous deleterious effects on parenting, 
increasing the risk of child maltreatment. Mothers with post-partum depression are at a greater 
risk for neglecting their infants. Mothers with post-partum depression are less likely to engage in 
behaviors important to the health and development of the infant, such as continued breastfeeding, 
establishing routines, reading or talking to the infant, and playing with the infant (McLearn et al., 
2006; Lieferman et al., 2005). Depressed mothers also assume a more authoritarian parenting 
style, as evidenced by their more controlling and punitive outlook towards childrearing (Field et 
al., 1985). An infant’s safety can even be jeopardized if a mother is clinically depressed: 
depressed mothers show a decrease in child safety behaviors, such as using car seats and 
seatbel
ose mothers experienced anxiety during pregnancy perform significantly 
lower o
ts, keeping poisons and firearms out of reach, and using electrical covers and safety 
latches (McLearn et al., 2006; Rhodes et al., 2007).  
Effects beyond the neonatal and post-partum stages on the offspring of a depressed or 
anxious mother have also been reported in the literature. Deave et al. (2008) studied the impact 
of maternal depressive symptoms on child development at 18 months, finding that maternal 
depressive symptoms during pregnancy were related to developmental delays in children 18 
months of age. A longitudinal study revealed that adolescents antenatally exposed to depression 
are 4.5 times more likely to experience depressive symptoms than adolescents who were not 
exposed to depression in-utero (Pawlby et al., 2009). Children of antenatally anxious mothers are 
more likely to present with behavioral/emotional problems at 4 years of age (O’Connor et al., 
2002). Adolescents wh
n cognitive tasks than adolescents of mothers who were not anxious during pregnancy 
(Mennes et al., 2006). 
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The health status and health behaviors of women suffering from depressed or anxious 
states during pregnancy may also be compromised. Self-reported measures of health and 
functional status for depressed pregnant women are lower than the reported scores of non-
depressed pregnant women (Orr et al., 2007), and women with high levels of depression are at 
twice the risk of experiencing impaired health and functional status. Behaviorally, substance 
misuse and dependency is of particular concern for depressed or anxious pregnant women. 
Substance abusing pregnant women are more likely to be depressed or anxious (Haller et al., 
1993), and substance dependency is independently associated with maternal depression (Pajulo 
et al., 2001). Depressed, pregnant women are also less likely to engage in important prenatal 
health behaviors, such as exercising, getting adequate sleep, and regularly taking prenatal 
vitamins (Lindgren, 2001; Allister et al., 2001). The weak maternal-fetal bond that develops 
betwee
periencing grave health consequences, a risk that can 
possibly be avoided by timely, effective treatment. The various treatment modalities for 
depression and anxiety in pregnant women and the respective effectiveness and safety of each 
modality will now be discussed in detail. 
n depressed mother and fetus (Lindgren, 2001) may contribute to the depressed mother’s 
tendency to engage in negligent or irresponsible health behaviors, such as not learning about 
pregnancy and smoking during pregnancy.     
Considering the numerous potential ways in which antenatal depression and anxiety can 
have negative effects on the mother and her child at various stages of growth and development, 
effectively treating a pregnant woman’s depression or anxiety is crucial to the health and well-
being of her offspring and herself. Letting the depression or anxiety go untreated puts the mother 
and child at heightened, undue risk of ex
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1.2 TREATMENT OF DEPRESSION AND ANXIETY DURING PREGNANCY 
Presently, treating pregnant women suffering from depression and anxiety with 
psychopharmaceuticals—such as SSRIs, tricyclic antidepressants, and benzodiazepines—is the 
most common treatment modality (Yonkers et al., 2009). These medications are the same 
medications used to treat non-pregnant women and men; they are not specifically manufactured 
for the unique physiology of a pregnant woman or the presence of a fetus. The impact of 
psychopharmaceuticals on the developing fetus and neonate is not yet definitively known, but 
evidence is amassing in the literature that suggests antenatal use of psychopharmaceuticals to 
treat depression and anxiety could potentially have adverse outcomes on the fetus and even the 
mother.  
Most research on antidepressants and birth outcomes has focused on selective-serotonin 
reuptake inhibitors (SSRIs) because these are the most commonly prescribed antidepressant 
medications for pregnant women. A higher rate of preterm delivery is the most consistently 
reported deleterious consequence of antenatal SSRI antidepressants. In a prospective 
observational study, preterm deliveries among women using SSRIs late in pregnancy exceeded 
20 percent, as compared to pregnant women with no SSRI use (Wisner et al., 2009). Previous 
studies conducted two years prior to Wisner et al. also reported increased risk of preterm delivery 
among pregnant women exposed to psychopharmaceuticals for treatment of depression and 
anxiety (Wikner et al., 2007; David et al., 2007). As mentioned previously, preterm delivery can 
be a very serious birth outcome. 
Along with preterm delivery, low birth weight among infants exposed to anti-depressants 
and anti-anxiety medications has been documented in the literature. In a study that examined 
birth weight and birth length of SSRI-exposed infants, the birth weight—and birth length and 
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head circumference—of the SSRI group was below the 10th percentile for age in more SSRI 
exposed infants than non-SSRI exposed infants (Davidson et al., 2009). Recall that low birth 
weight infants are at increased risk for mortality, morbidity, and long-term disability, rendering it 
a serious adverse pregnancy outcome (Goldenberg & Culhane, 2007). 
Several studies have also reported the phenomenon of neonatal abstinence syndrome 
(NAS)—or quite simply, withdrawal—in infants exposed to SSRIs and anti-anxiety medications 
during pregnancy. While this syndrome is transient in neonates, it is still a congenital condition 
that requires special attention and monitoring from medical professionals. Gone unnoticed, NAS 
can further add to the physiological distress the neonate is experiencing as result of exposure to 
anti-depressant pharmaceuticals. Levinson-Castiel et al. (2006) reported that up to 30 percent of 
antenatally SSRI-exposed infants presented with symptoms of NAS, which include 
tremulousness, gastrointestinal and sleep disturbances, hypertonicity, and high-pitched cry. Case 
reports of withdrawal symptoms in infants antenatally exposed to anti-anxiety medications late in 
pregnancy also exist in the literature (Rementeria et al., 1977) 
One of the most startling discoveries in research related to SSRI exposure and infant 
outcomes is an apparent association between maternal SSRI-use during pregnancy and increased 
rates of persistent pulmonary hypertension (PPHN) in exposed infants. PPHN is a serious 
condition that is associated with increased infant morbidity and mortality (Walsh-Sukys et al., 
2000). In a larger-scale repetition of a previous, smaller study on the topic, Chambers et al., 
(2006) found that there was a statistically significant association between use of SSRIs in late 
pregnancy and clinical presentation of persistent pulmonary hypertension in the respective infant.  
Yet another concerning finding surfacing about antenatal use of anti-depressants is the 
potential disruptive effect on the infant’s cardiac rhythm. There is evidence that SSRI-exposed 
 8 
infants may be at increased risk for QT interval abnormality; more specifically, SSRI-exposed 
infants are more likely to have prolonged QT intervals than their non-exposed counterparts. 
Dubnov-Raz et al. (2008) found that the mean QT interval in SSRI exposed infants was 
significantly longer than controls, and 10 percent of SSRI exposed infants had pathologically 
prolonged QT intervals. A prolonged QT interval is a very serious cardiac condition: it puts one 
at increased risk for sudden death and malignant arrhythmia (Moss et al., 1991).  
The neurobehavior of SSRI-exposed infants also seems to be disturbed when compared to 
non-SSRI-exposed infants (Boucher et al., 2007). SSRI-exposed infants suffer from sleep 
disorganization, a more active resting state, increased tremulousness and startles, and less 
autonomic physiological regulation (Zeskind & Stevens, 2004). More research on this topic is 
necessary to determine the incidence and severity of this side effect of SSRI exposure during 
pregnancy, and to differentiate it from neonatal abstinence syndrome. Longitudinal studies of 
SSRI-exposed infants’ neurobehavior would be helpful to determine the persistence of the 
disruptions in neurobehavior, thereby distinguishing it from NAS, which is a transient syndrome.  
A slight increased risk of congenital malformations is associated with antenatal use of 
anti-depressant and anxiety medication. Davis et al. (2007) showed that exposure to tricyclic 
anti-depressants in early pregnancy resulted in an increased risk for spina bifida and limb 
abnormalities in offspring. Among benzodiazepine exposed infants, 5.3 percent were identified 
as having malformations of some kind upon birth (Wikner et al., 2007). The risk of congenital 
malformations due to antenatal exposure to psychopharmaceuticals is not alarmingly high, but it 
poses enough risk to the fetus to cause concern.   
Research thus far on antenatal use of psychopharmaceuticals has mainly focused on the 
impact on the fetus and neonate: no attention has been given to the effects on the pregnant 
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woman herself until very recently. Toh et al. (2009) addressed the gap in the literature on 
antenatal exposure to psychopharmaceuticals and the impact on the mother in their study on 
antenatal exposure to SSRIs and risk of gestational hypertension.  In SSRI exposed mothers, 19.1 
percent presented with gestational hypertension, whereas only nine percent of non-SSRI exposed 
mothers met clinical requirements for gestational hypertension. Additionally, among SSRI-
exposed mothers, 15.2 percent were diagnosed with pre-eclampsia; only 2.4 percent of non-SSRI 
exposed mothers had pre-eclampsia. Pre-eclampsia is considered a very serious condition during 
pregnancy.   
In light of the emerging literature elucidating possible risks of antenatal use of 
psychopharmaceuticals, professionals in the women’s health and mental health fields decided to 
conduct a collaborative investigation to examine the issue further. A joint report issued by the 
American Psychiatric Association and the American College of Obstetricians and Gynecologists 
(Yonkers et al., 2009) reviewed all the extant literature on outcomes studies on anti-depressants 
during pregnancy and used the findings to formulate treatment guidelines for practicing 
clinicians. The report raises pertinent points about various confounding factors that have yet to 
be controlled for in the outcomes studies; these factors range from the presence of depression 
itself, maternal illness, and maternal health behavior. Even with the acknowledgement of these 
methodological shortcomings in the available studies, it was still suggested that pre-conceptional 
patients currently on medication who have mild depressive symptoms or have been 
asymptomatic for 6 months or more undergo medication taper and eventual complete medication 
discontinuation before conception is attempted.   
Additionally, qualitative studies investigating pregnant women’s thoughts on taking 
psychopharmaceuticals reveal that pregnant women themselves are hesitant about using 
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medications to treat their depression or anxiety during pregnancy and during the immediate 
postpartum period. One study found that only 35 percent of women in the perinatal phase would 
consent to the recommendation of taking psychopharmaceuticals to treat their depression 
(Goodman, 2009). A more in-depth, exploratory study of depressed women’s preferences for 
mental health treatment during pregnancy revealed that women had the lowest confidence in 
antidepressant medications (O’Mahen & Flynn, 2008). Women who have recently given birth 
have raised concerns about safety during breastfeeding and the potential for side effects (i.e. 
drowsiness) to deter from parenting ability (Turner et al., 2008). A lack of non-pharmacological 
treatment options could be one reason why only 18 percent of pregnant women experiencing 
negative affective states seek treatment for their symptoms (Marcus, 2009). 
Given the inconclusive empirical evidence on the safety of antenatal use of 
psychopharmaceuticals to treat maternal depression and anxiety, along with the professional and 
patient concern over their safety, finding non-pharmacological treatment modalities that are 
equally effective—but without possible deleterious effects on the developing fetus, neonate, and 
mother—is imperative to the overall health of mother and child. Furthermore, treating antenatal 
depression with psychopharmaceuticals may be replacing one risk factor with another: the 
potential adverse outcomes of psychopharmaceutical use during pregnancy are similar to that of 
untreated antenatal depression and/or anxiety. With the health of two individuals simultaneously 
threatened—the mother and the child—safe, effective treatments are all the more necessary. 
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1.3 NON-PHARMACOLOGICAL TREATMENTS FOR ANTENATAL 
DEPRESSION AND ANXIETY 
Some alternative treatment options are currently available for pregnant women suffering from 
depression, such as electroconvulsive therapy (ECT) or increased omega-3 fatty acid intake. 
However, ECT itself is a controversial treatment modality for pregnant women suffering from 
depression. Effectiveness rates in preventing relapse of a depressive episode, albeit impressive, 
have been determined from case reports of physicians that have used ECT for their pregnant, 
depressed patients; no randomized controlled trials evaluating the use of ECT for pregnant 
women have been conducted (Anderson & Reti, 2009). Furthermore, reports of perinatal 
complications continue to surface in the literature, causing obstetrician/gynecologists to 
“conclude that there are insufficient data to support the American Psychiatric Association’s 
position that ECT has ‘low risk’ in all three trimesters of pregnancy” (Richards, 2007).   
Research on omega-3 fatty acid intake for pregnancy women is in its infancy, but has 
yielded promising results. A small open trial of omega-3 fatty acids with depressed pregnant 
women showed decreases in depressive symptomalogy as a result of omega-3 fatty acid intake 
(Freeman et al., 2006). The only randomized, double-blind, placebo-control trial to date of this 
alternative treatment for pregnant women with depression did report favorable outcomes: 
depressive symptoms significantly improved among women in the treatment group (Su et al., 
2008). Larger replications of this trial are needed to address the issues of safety and 
psychotherapeutic effect for the woman. Furthermore, while non-pharmacological, omega-3 
supplements are still an invasive form of treatment whose effects on the developing fetus and 
future neonate have not yet been empirically determined.  
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Non-invasive treatment options available include psychotherapy, bright light therapy, 
exercise, massage, and acupuncture. Psychotherapy appears to be effective, but is time 
consuming and not economically feasible for many women; exercise has only a slight effect on 
ameliorating depressive symptoms. In a Cochrane Collaboration review (Dennis & Allen, 2009) 
of non-pharmacological interventions for antenatal depression, it was determined that massage 
and acupuncture treatments did not significantly decrease depressive symptoms in pregnant 
women. In the same review, the methodology of a bright light therapy study did not even meet 
inclusion criteria for the review.  As such, there is a need for additional non-invasive, effective 
treatments that pregnant women can choose from when deciding how to manage their depression 
and anxiety. 
1.4 MINDFULNESS: AN OVERVIEW 
Mindfulness is a practice rooted in Buddhist practice and philosophy, but its premise is simple 
and has a secular quality to it: nonjudgmental acceptance and awareness of the present moment. 
This is usually achieved through a meditative practice that focuses on the flow of the breath, and 
it is an actively engaged process. The final result of this practice and mindset is an existence 
characterized by non-attachment to thoughts, beliefs, and emotions, which consequently 
produces a mental state that is more balanced. Regular practice of mindfulness meditation can 
have lasting physiological changes on the body as well, even resulting in changes in brain 
activity. Thus, it is not surprising that regular practitioners of mindfulness report increased 
calmness and a general sense of overall physical and mental well-being. 
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Mindfulness as it is defined in this study is not to be confused with the Westernized 
versions of mindfulness that have developed in an attempt to make it more conducive to 
scientific inquiry. One Westernized approach towards mindfulness began with the rigorous study 
of mindlessness and the subsequent consequences that result from interacting with the world in a 
mindless psychological state; only after these experiments on mindlessness did the concept of 
mindfulness crystallize (Langer, 1989). Quite simply, mindfulness is the absence of 
mindlessness, according to this perspective. Cultivating mindfulness according to this 
conceptualization of mindfulness is not done through any semblance of meditative practice. 
Furthermore, this group of mindfulness researchers acknowledges that their definition of 
mindfulness may draw parallels between the Buddhist conceptualization of mindfulness, but they 
stress that their mindfulness in one entirely spawned out of the Western scientific paradigm.  
Admittedly, one could argue that even those researchers who study Eastern mindfulness 
are bastardizing mindfulness—modifying it to make more congruent with Western ideology—by 
the mere fact of subjecting it to empirical study, but they do not attempt to make a distinction 
between Eastern and Western mindfulness. While they do extract mindfulness from the Buddhist 
religion to make it more palatable to Western practitioners, and oftentimes simplify or condense 
the meditative practice required to cultivate mindfulness, the essence of Eastern-originated 
mindfulness is steadfastly preserved and honored in their work. 
1.5 MINDFULNESS APPLIED TO CLINICAL SETTINGS 
Extensive practice is not required to cultivate mindfulness or to experience the benefits 
associated with its practice. Recent research has shown that mindfulness can be taught in a 
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condensed manner, and when applied to the health setting, mindfulness has a multitude of 
benefits (Ludwig & Kabat-Zinn, 2008). Patients, providers, and the overall quality of care 
delivered by medical professionals prosper in a myriad of ways from the introduction of 
mindfulness into clinical practice.  
The particular condensed, clinical adaptation of mindfulness through which individuals in 
the health care setting enjoy the benefits of mindfulness is by administration of an empirically-
tested intervention called mindfulness-based stress reduction (MBSR). Recipients of the 
intervention attend an 8-week, intensive training in mindfulness meditation intended to give 
participants the skills needed to cope with stress and other negative feelings in their everyday 
lives (Kabat-Zinn, 1993). MSBR is the mindfulness-based intervention that is gaining the most 
attention in the clinical realm, whether in practice or research. It has been used with patients in 
various health populations and with clinicians, and its effectiveness has been the subject of 
numerous research studies. However, it should be noted that there are other mindfulness-based 
interventions being used in clinical settings and subjected to empirical study. Some are not based 
on MSBR, while others may be a variation of MSBR. 
Mindfulness-based interventions have been shown to be effective in reducing stress and 
facilitating coping in different populations suffering from various health problems: cancer, 
depression, anxiety, chronic heart failure, and chronic pain (Carlson et al., 2001; Teasdale et al., 
2000; Evans et al., 2008; Sullivan et al., 2009; Kabat-Zinn, 1982). Participants in these studies 
received MBSR to help alleviate the negative affective states that oftentimes accompany physical 
morbidity, and their outcomes were compared with individuals who receive standard coping 
interventions for their respective physical malady. In addition to empirical support for MBSR 
reducing stress in patient populations, patient satisfaction with the intervention is also favorable 
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(Kievet-Stijnen et al., 2008). Satisfaction and reduction of negative affective states proved 
sustainable in 6-month and 1-year follow-up evaluations. 
Burnout is a recognized phenomenon among practicing clinicians, and it is increasingly 
demanding the attention of medical professionals as a negative presence that needs to be 
remedied. The clinical work of clinicians experiencing burnout suffers, which not only puts 
patients’ safety at risk, but diminishes the sense of satisfaction the patient has with the clinician-
patient relationship (Vahey et al., 2004; Ratanawongsa et al., 2008). Burnt out clinicians even 
realize that the quality of care they provide to patients is substandard (Spickard et al., 2002). 
Physicians and other health care professionals who receive a mindfulness-based intervention for 
burnout-related symptoms have noted improved job satisfaction and reduced stress levels 
(Shapiro et al., 1998; Shapiro et al., 2005; Galantino et al., 2005). Hence, mindfulness has the 
potential to counter the occurrence of clinician burnout, which will ultimately lead to improved 
clinical work and patient satisfaction. 
Mindfulness is associated with empathy (Beitel et al., 2005; Dekeyser et al., 2008), and, 
in addition to ameliorating stress, mindfulness has been shown to increase levels of empathy in 
medical students (Shapiro et al., 1998). In a model of developing healing relationships between 
clinician and patient, valuing—which entails the creation of a nonjudgmental emotional bond—
is the foundation of the development of the healing relationship (Scott et al., 2008). Also, 
patients continually express a preference for doctors who are more compassionate and empathic: 
they want physicians that genuinely listen to their concerns (Jangland et al., 2009). Therefore, 
with compassion as a necessity and preference in the healing relationship between clinician and 
patient, integrating mindfulness into clinicians’ practice could ensure the presence of this very 
important quality. 
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Another benefit to clinician mindfulness practice is a reduction in medical errors. 
Malpractice as a result of poor judgment, oversight, and perfunctory responses to common 
illnesses or disorders is common (Kachalia et al., 2007). The majority of these missteps could 
easily have been prevented, as they were not the result of incompetence, but rather 
inattentiveness and routinized behavior (Groopman, 2007). Groopman further suggests that one 
possible approach to counter these “cognitive traps” is to adopt a self-reflective style of thinking 
that is similar to mindfulness. 
Mental health practitioners are also employing the philosophy of mindfulness to help 
treat mental and behavioral health disorders. Evidence-based treatments such as Dialectical 
Behavioral Therapy and Acceptance and Commitment Therapy infuse certain components of 
their treatment protocols with mindfulness-based exercises and philosophy (Linehan, 1993; 
Hayes et al., 1999). Mental health patients who received treatment from a clinician trained in 
mindfulness showed more symptom reduction on indices of anxiety than did patients treated by a 
clinician with no mindfulness training (Grepmair et al., 2007). However, these treatments do not 
use mindfulness as the predominant theoretical framework to guide their treatment protocols, 
making it difficult to discern if the therapeutic effect can be solely attributed to the mindfulness 
component. The empirical support for another form of therapy called Mindfulness-based 
Cognitive Therapy may be better suited to determining the effects of mindfulness on one’s 
mental and behavioral health.  
Controlled research trials of Mindfulness-based Cognitive Therapy (MBCT)—an 
innovative adaptation of Cognitive Behavioral Therapy—are providing empirical support that 
mindfulness-based therapeutic interventions are effective in preventing relapses of depressive 
episodes (Kuyken et al., 2008). MBCT combines mindfulness-based stress reduction with 
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cognitive behavioral therapy to teach patients with major depression to become aware of internal 
sensations and thoughts that accompany the onset of a depressive relapse. Kuyken et al. (2008) 
found that MBCT is equally as effective as anti-depressant medications in preventing relapse and 
superior to anti-depressants on quality of life measures. Mindfulness-based approaches to 
treatment have also shown effectiveness in treating substance abuse: substance abusers who 
received a mindfulness meditation intervention showed significant decrease in the amount of 
chemical substances (alcohol, marijuana, and crack cocaine) consumed (Bowen et al., 2006). 
1.6 MINDFULNESS APPLIED TO DEPRESSED OR ANXIOUS PREGNANT 
WOMEN 
ess-based interventions could afford pregnant women suffering 
from de
Mindfulness-based stress reduction has been shown to reduce elevated levels of cytokines in 
other populations experiencing stress, anxiety, and depression (Witek-Janusek et al., 2008). 
Recall from the previous discussion of the adverse birth outcomes associated with stressed 
and/or depressed pregnant women that heightened level of cytokines in their blood is drawing the 
attention of researchers as a potential casual pathway for the reported negative birth outcomes 
(Coussons-Read et al., 2007). Consequently, there is a strong possibility that mindfulness-based 
stress reduction would have a similar, positive impact on the immune response of stressed, 
anxious, and/or depressed pregnant women. Emerging studies are providing empirical evidence 
for the inferred benefits mindfuln
pression and/or anxiety. 
One study investigated the effectiveness, feasibility, and acceptability of a yoga program 
infused with mindfulness-based stress reduction for pregnant women experiencing elevated 
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levels of distress (Beddoe et al., 2009). The results indicated that the program assuaged women’s 
stress and anxiety in their third trimester of pregnancy, and most participants were amenable to 
the mind-body approach of the intervention. However, due to the combination of yoga and 
mindfulness-based stressed reduction, it is difficult to discern what aspect of the program 
contributed to these favorable results: was it the yoga component or the mindfulness component, 
or the c
eported significantly decreased anxiety and negative 
affect w
ditation was therefore unprompted and non-iatrogenic, 
entirely
ombination of both?    
In a recent pilot study among pregnant women (Vieten & Astin, 2008), a mindfulness 
meditation intervention was developed to reduce depressive symptoms during pregnancy and the 
early postpartum period. The intervention is called Mindful Motherhood, and it uses a three-
pronged approach towards cultivating mindfulness in the expectant mother: breath awareness to 
promote mindfulness of thoughts and feelings, guided body awareness to promote mindfulness 
of body, and acceptance and cultivation of an observing self. The results of the study showed that 
women who received Mindful Motherhood r
hen compared to wait-list controls.  
Pregnant women themselves seem to want the availability of a treatment option that 
includes meditative practices. In a focus group study intended to elicit depressed pregnant 
women’s attitudes and thoughts on treatment and treatment preferences, women expressed the 
desire to have treatment options to choose from to manage their depressive symptoms that 
included meditation or yoga (Jesse et al., 2008). It should be noted that participants were not 
asked specific questions about their preference for treatment options that included a meditative 
component; this response pertaining to me
 the preference of the participant. 
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While not yet empirically studied, teaching mindfulness-based interventions to 
antenatally depressed or anxious mothers could also potentially act as a protective or mediating 
factor in relation to the development of post-partum depression. As mentioned previously, 
antenatal depression or anxiety is often a risk factor for subsequent development of post-partum 
depression. A non-invasive method for treating antenatal depression or anxiety that also acts as a 
prevent
idence of mindfulness-based interventions’ 
effectiv
on-psychopharmaceutical, non-invasive treatment for depressed or anxious 
pregnant women to choose from responds to their preference for the availability of this type of 
treatment option. 
ative measure would be an efficient and cost-effective way to combat two threats to 
maternal and child health.  
Despite a dearth of research on mindfulness-based interventions for depressed and/or 
anxious pregnant women, it appears that mindfulness-based interventions have the potential to be 
an effective, non-invasive treatment for women experiencing anxiety and depression during 
pregnancy. Considering the burgeoning amount of ev
eness with other populations, the likelihood these interventions would have the same 
beneficial effect on this specific population is good.  
Attenuating anxiety and depression in pregnant women is important given the large body 
of empirical evidence that anxiety and depressed mood during pregnancy are correlated with 
adverse birth outcomes (Dayan et al., 2002; Borders et al., 2007). Given the inconclusive 
evidence in regard to the safety of psychopharmaceutical treatment for antenatal depression or 
anxiety, a non-invasive approach to treatment like mindfulness-based interventions could be a 
safe, effective alternative to pregnant women suffering from depressive or anxious symptoms. 
Additionally, a n
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1.7 PROVIDER ADOPTION OF MINDFULNESS TO TREAT DEPRESSION AN
ANXIET
D 
Y 
With the promising evidence that mindfulness-based stress reduction is an effective, non-
invasive means to treat maternal depression and anxiety, the next step is to successfully 
disseminate the practice of using mindfulness-based stress reduction with the population of 
depressed and anxious expectant mothers. Successful dissemination begins with an 
understanding of the perspectives and attitudes towards the intervention of those who will be 
administering or practicing the intervention (Aarons, 2005). By discussing mindfulness 
interventions with prenatal care providers, it can help predict the likelihood that mindfulness will 
be adopted as part of routine practice by clinicians, as well as to determine whether there are 
barriers to clinician support of mindfulness as a treatment option for pregnant women with 
negative emotional states. There are no studies in the extant literature that provide information 
on the attitudes towards mindfulness of any type of clinician—obstetrician/gynecologists or 
midwives—that provides care to pregnant women. 
Mindfulness is often considered a complementary intervention to mainstream modes of 
clinical practice. Complementary treatments are anything “not currently part of the dominant or 
conventional medical system” (Allaire et al., 2000). The extant literature pertaining to the 
integration of complementary treatments with prenatal care and birthing services reveals that 
midwives—not obstetrician/gynecologists—are more likely to incorporate complementary 
treatments into their practice. One study revealed that complementary treatments were 
recommended by 93 percent of midwives within the past year, and 57 percent of midwives used 
complementary methods to treat more than 10 percent of their pregnant patients (Allaire et al., 
2000). The same study also found that midwives use mind-body interventions to treat anxiety 
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and stress in their pregnant patients, such as biofeedback and hypnosis; mindfulness was not 
mentioned. Not surprisingly, qualitative studies done on midwives’ perspectives and attitudes 
towards using complementary treatments report favorable attitudes towards supplementing 
standard practice with complementary treatments (Adams, 2006; Williams & Mitchell, 2007). 
No studies have been done specifically investigating midwives’ use and perceptions of 
mindfulness and mindfulness-based interventions in the clinical setting. The evidence pertaining 
to use and perspectives towards complementary medicine suggests that midwives’ would most 
likely be receptive to incorporating mindfulness philosophy and interventions into their practice. 
In particular, it also implies that midwives would be amenable to using or recommending 
mindfulness-based interventions for their depressed and/or anxious patients.  
In addition to the classification of mindfulness as a complementary treatment modality—
which midwives endorse and practice—there are certain philosophical similarities between 
midwifery practice and mindfulness that render the fusion of the two disciplines conceivable. 
Midwives are known for their more holistic, humanistic approach to pregnancy and the birthing 
process, placing emphasis on being present with the woman during child birth (Cragin, 2003). To 
reiterate from the previous overview of mindfulness, one component of the essence of 
mindfulness is full awareness of and immersion in the present moment. Midwifery also 
champions a non-judgmental, empathic honoring of the woman’s needs and care requests, often 
encouraging assuming the perspective of the woman (Cragin, 2003). A tenet of mindfulness 
similar to this tenet of midwifery is the non-judgmental experience of the present moment. These 
philosophical similarities between midwifery and mindfulness suggest that the two would fit well 
together in a commensal relationship of sorts, with the field of midwifery benefiting from the 
constant presence and influence of mindfulness. 
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A complementary treatment such as a mindfulness-based intervention is also a non-
invasive form of treatment for depression and/or anxiety. Another tenet of midwifery practice is 
the approach of least intervention: midwives strive to act in a manner that is not invasive to the 
experience of pregnancy and birth. Therefore, a non-invasive approach such as mindfulness-
based interventions in managing pregnant women’s depression and/or anxiety would most likely 
be embraced by practicing midwives. Pregnant women themselves also prefer non-invasive 
forms of managing depression or anxiety, and midwives would readily honor this preference 
given it is part of midwifery credo to respect the prenatal care preferences and decisions of the 
women they provide care to.    
Hence, the philosophical similarities of midwifery and mindfulness suggest a plausible 
marriage of the two disciplines, but without any research on the topic, the likelihood of such a 
union is difficult to predict. It is curious that the relationship between midwifery and mindfulness 
has not been given more attention by researchers. This study addressed the gap in the literature 
pertaining to the perspectives of midwives towards using mindfulness in their clinical practice 
and to help their patients suffering from depression and/or anxiety. 
1.8 THEORETICAL FRAMEWORK 
In addition to being a complementary practice, mindfulness is also an innovative practice, even 
though its origins are steeped in ancient philosophical beliefs and religious practices. Innovations 
are any interventions that are perceived as new by the majority in a particular field; using 
mindfulness to supplement and enhance clinical practice is a new concept to many clinicians. As 
such, using Diffusion of Innovations theory (Rogers, 2003) to conceptualize the uptake of 
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mindfulness in clinical settings is a useful way to predict the course of its implementation. 
According to Diffusion of Innovations theory, adoption depends on the characteristics of the 
individuals that will be using the intervention: the adopters (Rogers, 2003). In the case of the 
proposed study, midwives occupy the role of adopter.  
There are five categories of adopters: innovators, early adopters, early majority, late 
majority, and laggards. Each category has a unique set of characteristics that individuals embody 
as adopters. Innovators are defined by their venturesomeness and a position of notable leadership 
and influence in their respective fields. Early adopters reduce suspicion or uncertainty about an 
innovation by adopting it; this bold decision acts as a catalyst to others adopting the innovation. 
The early majority mull over the prospect of adopting an innovation, adopting new ideas not that 
long before the average member of the system. The late majority have a high degree of 
skepticism towards the innovation, delaying their adoption of the innovation until just after the 
average member. Finally, laggards are synonymous with the past; they are resistant to change, 
and are the very last to adopt the innovation, if they adopt it at all. It is hypothesized that 
midwives will possess the characteristics common to early adopters.  
The information gathered from this exploratory, qualitative study can be used to guide the 
implementation efforts of the innovative treatment modality of mindfulness among pregnant 
women to improve birth outcomes. It is also the first study to examine practitioner perspectives 
on using mindfulness in clinical settings, and could serve as a catalyst to more research being 
conducted on this topic. Implementation initiatives of other mindfulness interventions for various 
health conditions and populations would benefit from such information. Therefore, gaining an 
increased understanding of adoption and implementation of mindfulness is a pioneering step 
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towards maximizing the potential of mindfulness to improve maternal and child health, and 
public health in general. 
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2.0  METHOD 
Participants were practicing midwives (N = 6) in Western Pennsylvania and Vermont. 
Originally, 12 midwives were contacted to participate in the study. Of the 12, 6 consented to 
participation. Midwives were varied in the type of clinical setting in which they worked: some 
midwives worked in a hospital setting under collaborative agreements with 
obstetrician/gynecologists and some midwives worked in independent midwifery clinics. A 
regional representative of a midwife organization in Pennsylvania volunteered to help recruit 
midwives for the study. She made fellow midwives aware of the study via a list serve 
announcement; interested midwives contacted the principal investigator via e-mail. The regional 
representative also offered to have the principal investigator attend a monthly midwife meeting 
to recruit more participants. The principal investigator attended the meeting and gave a very brief 
description of the study to the group. Names and contact information were collected from 
midwives who were interested in participating in the study. Vermont midwives were recruited 
via a connection one of the investigators had with one of the midwives. The principal 
investigator e-mailed all interested midwives, providing them with more information on the 
study, and all study documents: informed consent and a scholarly article on mindfulness. If the 
midwives did indeed want to participate in the study, they signed and returned the informed 
consent form to the principal investigator. An interview time was then arranged that was 
convenient for the participant.  
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Individual phone interviews were conducted with each midwife to gather information on 
their perspectives on using mindfulness in clinical practice. Interviews lasted no more than 20 
minutes, and were conducted with the aid of an interview guide designed before inception of the 
study. The interview questions were intended to elicit the midwives’ overall perspective on 
mindfulness by addressing five specific aspects of mindfulness and clinical settings: 1.) 
mindfulness’s fit with general clinical practice, 2.) mindfulness’s fit with midwifery practice, 3.) 
mindfulness’s impact on the midwives’ personal practice, 4.) mindfulness’s effectiveness in 
intervening with depressed or anxious women, and 5.) barriers that may impede the use of 
mindfulness in clinical settings. Examples of questions include “How does mindfulness 
specifically relate to clinical practice as a midwife?” and “How do you think mindfulness-based 
interventions will affect your pregnant patients’ anxiety and depression levels?” The interview 
guide was designed by the Principal Investigator and refined with the input of a professional who 
had prior experience with conducting phone interviews for research purposes. 
During the course of the interviews, interviewers took detailed notes of the responses 
from the midwives. The midwives were instructed to read the peer-reviewed article on 
mindfulness before the interview. The purpose of the article was twofold: 1.) to provide the 
midwives with a primer on what mindfulness is and how it is currently being applied to the 
clinical setting and 2.) to promote a standardized conceptualization of mindfulness across the 
participants. University of Pittsburgh Institutional Review Board approval was obtained prior to 
initiation of the study. 
Field notes of the interviews were analyzed using a grounded theory approach. One 
member of the research team read through the field notes, looking for recurring themes that 
emerged, and a codebook was subsequently developed. Two members of the research team 
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independently coded the interview content according to the codebook. The coding team’s coding 
decisions were then discussed in order to obtain consensus. In situations where there was a 
discrepancy between how the coders coded a particular piece of data, the coders discussed the 
content until a consensus was reached. Original themes were finalized using a constant 
comparative method, and themes were expanded, collapsed, or eliminated accordingly. 
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3.0  RESULTS 
E 
For each of the five aspects of mindfulness that were inquired about, predominant themes 
emerged upon analysis of the interview content. More detailed explanations of the themes with 
relevant exemplars are provided below. 
3.1 MINDFULNESS’S FIT WITH GENERAL CLINICAL PRACTIC
Three predominant themes were discussed by the midwives in relation to how they thought 
mindfulness may be useful in general clinical practice. They thought it would be Useful in 
Decision Making, Increase Patient Attention, and Minimize Rushing. Decision making was seen 
as something that would benefit from incorporating mindfulness into general clinical practice. 
One midwife commented “For more accurate diagnosis and decisions, mindfulness is key.” 
Another midwife thought that mindfulness would “help to get better information from [the] 
patient and [contribute to] making better decisions.” 
Midwives also thought that a mindfulness-centered approach would increase the amount 
of quality attention they gave to their patients. One midwife thought that mindfulness “could be 
helpful during a busy day, to be with a woman and her family, and being present and making the 
family feel heard, so they can fully discuss health and birth-related issues.” Another midwife 
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echoed the same sentiments, simply stating that mindfulness could help to “take time and listen 
to the person” you are treating at the time.  
Finally, midwives expressed the feeling that mindfulness would help minimize the rushed 
pace at which their work oftentimes functioned. One midwife stated that mindfulness “would 
help with rushing in between visits.” One midwife who had previous adopted a mindfulness-
based approach to her practice shared that “patients felt they weren’t rushed and that the 
clinicians were focused on them.” 
3.2 MINDFULNESS’S FIT WITH MIDWIFERY 
Three predominant themes surfaced upon analysis of midwives’ views on mindfulness’s 
relevance to midwifery practice. These themes were Philosophical Similarity, Increased 
Efficiency, and Facilitates Focus. Many midwives noted the similarities in the philosophical 
approaches of mindfulness and midwifery. One midwife said that “mindfulness is a nebulous 
thing, but part of midwife philosophy. If [one] can incorporate [mindfulness], it would help with 
this (being true to the midwife philosophy).” Another midwife had a similar point of view, as 
revealed by her comment: “Midwifery philosophy is based on being with a woman, and seeing 
things from her point of view. Mindfulness fits with the philosophy of being a midwife.”   
Midwives also felt that mindfulness would enhance the efficiency of their work, in 
timeliness and process. A midwife whose practice did incorporate some mindfulness approaches 
admitted that by using mindfulness, she “finds that appointments only take 40 minutes, instead of 
an hour, and it helps get to the point faster, eliminating unnecessary chitter chatter.” Another 
midwife who already uses a mindful approach to practice said that it helps to “pick up 
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complications sooner and be more accurate and timely in addressing these complications.” 
Another midwife thought that mindfulness would “help to make sure she wasn’t missing things” 
during appointments. Yet another midwife asserted that mindfulness “will help to act for a good 
reason, not acting for the sake of acting, and this will help to improve outcomes.”  
Midwives also discussed the importance of mindfulness in helping the busy midwife stay 
focused on the task at hand before her. One midwife spoke about how “working in hospitals with 
4 women laboring at a time, it’s hard to focus on 1 patient when there are 3 others. 
[Mindfulness] helps to be present with the woman during labor…”  Another midwife thought 
that mindfulness would “promote focused multi-tasking.” Yet another midwife reiterated the 
feeling that mindfulness promotes focus, saying that mindfulness “helps to focus on what needs 
to be done.” 
3.3 MINDFULNESS AND MIDWIVES’ PERSONAL PRACTICE 
Three main themes emerged in relation to how midwives thought mindfulness would impact 
them individually in their own personal practice as a midwife: Increased Satisfaction, Promotes 
Clarity, and Fosters Empowerment. Midwives thought that mindfulness would increase their 
personal satisfaction with their work and consumer’s satisfaction with the services that they 
received. One midwife said that it “would lead [her] to feel more satisfied and less burnt out.” 
Another midwife thought mindfulness “would be ideal if it could be used in all situations, 
[resulting in] better consumer satisfaction.” Mindfulness was also seen by midwives as a means 
through which to enhance clarity during the course of a chaotic workday. One midwife 
commented that mindfulness “allows for inner peace in the midst of chaos and crisis, helping to 
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bring clarity.” Another midwife shared this view of mindfulness promoting clarity “in the 
context of swirling around, and chaos, around and underneath you.”  
Midwives felt that mindfulness would help them foster a sense of empowerment in their 
patients.  If embodying the approach of mindfulness, one midwife felt that she would “be able to 
help the patient make sound decisions. The patients will be able to make their own choices in a 
non-judgmental way, and will be more likely to follow through on the decisions that they make.” 
Another midwife thought that mindfulness “lets women identify fears that are theirs, in the 
present,… sweeping out fears related to culture, medical society, mothers, TV, etc.” 
3.4 MINDFULNESS’S EFFECTIVENESS WITH DEPRESSED OR ANXIOUS 
PREGNANT WOMEN 
Two main themes were discovered pertaining to midwives’ thoughts on the impact of using 
mindfulness with their depressed or anxious patients. These themes were Optimistic Uncertainty 
and Calming Effect. Some midwives had an uncertain, yet optimistic view as to whether or not 
mindfulness would help their depressed or anxious patients. This theme is probably best 
represented by a midwife who admitted that she “didn’t know, but thinks [mindfulness] would be 
helpful” in alleviating negative affective states in pregnant women. Similarly, another midwife 
said that using mindfulness with depressed or anxious pregnant women would “probably would 
help quite a lot,” but that she “doesn’t know how [she’d] exactly use it.” The same midwife said 
that, given her uncertainty, she “would like to make referrals to therapists who have a 
mindfulness background,” rather than address the anxiety or depression in her patients herself, 
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but if “easy tools, such as handouts or a specific exercise” were available, this might give her a 
clearer idea of how to use mindfulness herself.  
Midwives who were not uncertain about mindfulness’s utility in intervening with 
depressed or anxious pregnant women thought that it would have a calming effect on the women. 
One midwife offered that “a calmer, cleaner space (attributed to mindfulness) will lead to 
reduced anxiety.” Another midwife thought mindfulness would have a positive, calming effect 
“by eliminating fears that don’t belong to [the women].” Yet another midwife posited that by 
“spending more time talking and listening to the patient would calm them, and would also add 
reassurance and help relieve their fears.” 
3.5 BARRIERS TO USING MINDFULNESS IN CLINICAL SETTINGS 
Two main themes were mentioned by midwives when discussing their thoughts on barriers to 
implementing mindfulness in clinical settings: Acceptability and Lack of Skill. Many of the 
midwives doubted that mindfulness would be accepted by their colleagues, patients, or those in 
more administrative healthcare positions. One midwife attributed this closed-mindedness to the 
recent trend and push towards evidence-based practice in clinical settings: “Mindfulness would 
get in the way of the push for evidence-base. Midwives are already considered a nebulous thing; 
using something that has no evidence of effectiveness may turn some people off.” Some 
midwives saw the lack of acceptability as the result of being unfamiliar with the concept of 
mindfulness, as described by one midwife: “The vocab would be uncomfortable to them, and 
they would think it’s amusing, but nothing more.” Another midwife also thought that “some 
people might not have the background, so it would be hard to explain, and might not be 
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accepted.” The philosophy of mindfulness itself is another factor that midwives thought would 
contribute to unwillingness to adopt its practices. One midwife said that “for some people, the 
idea of taking time out, they would react to this.” The same midwife also thought that “the idea 
of something based in Eastern philosophy” would make mindfulness less acceptable to some 
people.  
Lack of Personal Skill in their ability to practice mindfulness themselves also was 
mentioned by midwives as a potential barrier or concern when using mindfulness in clinical 
settings. One midwife candidly admitted that her “skills aren’t good enough and [she] would 
like to hone [her] mindfulness skills.” Another midwife was comparably blunt, saying that she 
“would like training, that [she] has trouble being in the here and now, [her] mind is all over the 
place.” 
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4.0  DISCUSSION 
Antenatal depression and anxiety are significant public health problems that require medical 
attention. Treating depression and anxiety during pregnancy is imperative to the health of the 
mother and child. Currently, the most common treatment modality is psychopharmaceuticals, but 
a plethora of outcomes studies on using psychotropic drugs to treat depressed or anxious women 
is revealing potential adverse outcomes for the mother, fetus, infant, and older child. 
Furthermore, pregnant women themselves are expressing a preference for non-
psychopharmaceutical treatment of their depression or anxiety.  
Alternative treatments to anti-depressant and anti-anxiety medications do exist, but their 
efficacy is questionable, as well as the safety of some of them. Mindfulness-based interventions 
show promise for being an effective, non-invasive means of managing negative affect states such 
as depression and anxiety. As an innovative approach to treating depression and anxiety, it has 
not yet been widely disseminated in clinical settings, nor has attention been given to predicting 
the likelihood that it would be adopted by clinicians who provide maternal and child health care. 
The attitudes towards a treatment modality of those who will be implementing the treatment 
greatly influence the implementation efforts. The present study explored midwives’ perspectives 
on mindfulness and using mindfulness-based interventions with their depressed and anxious 
patients. 
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The results of the study indicated that midwives were extremely receptive to the general 
concept of mindfulness and integrating it into the clinical setting. Such an open-minded attitude 
bodes well for the potential adoption of an innovative clinical venture, such as fusing an Eastern-
based practice—mindfulness—with Western medicine. Furthermore, many midwives thought 
that using mindfulness with their depressed or anxious patients would have a calming effect on 
the psychosocial state of the women. Midwives’ general receptivity to mindfulness philosophy 
coupled with their specific positive attitude towards mindfulness for depressed or anxious 
pregnant women suggests the adoption of mindfulness by midwives would be smooth.  
And while some midwives expressed an uncertainty about how they would use 
mindfulness to help their patients suffering from depression or anxiety, it was an optimistic 
uncertainty: they were unsure of how it would impact them, but believed it would most likely 
have a positive, beneficial effect. Having tools—such as specific mindfulness exercises—were 
even mentioned as something the midwives would like to have in their repertoire of clinical 
skills to use with their depressed or anxious patients. Hence, it is likely that any mindfulness-
based interventions developed for alleviating depression and anxiety in pregnant women would 
be successfully implemented by midwives. 
However, serious consideration should be given to the comment one midwife made about 
feeling more comfortable referring depressed or anxious patients to therapists with a 
mindfulness-based approach to treatment, rather than the midwives attempting to intervene on 
their own. If anxiety is transient, and more of a reaction to fears and uncertainty over pregnancy 
and birth, then it seems acceptable to encourage midwives to use mindfulness-based approaches 
to attenuate this manifestation of anxiety. Many midwives in the study acknowledged that they 
do see patients who are nervous or anxious about pregnancy-related issues, and that a 
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mindfulness-based approach may help to address these anxieties and fears, ultimately 
extinguishing them.  
However, anxiety that has a more chronic and severe quality to it—as well as any 
depressive symptoms midwives may observe in their patients—should be treated with the help of 
a trained psychologist or psychiatrist. Midwives could build screening for depression or anxiety 
into part of their regular routine during appointments, referring women to mental health 
professionals as they deem appropriate. Such a clinical practice seems to be a feasible request to 
make of midwives.  
One study exists that examined the role of midwives and nurses in screening for 
depression, with the specific intent of early detection of post-partum depression (Hanna et al., 
2004). The midwives involved in the study reported favorable attitudes towards incorporating 
screening into their practice, and felt screening for depression and anxiety during pregnancy was 
a very important clinical procedure to adopt. Midwives were also commendable in their reaction 
to discovering their patients were experiencing symptoms of depression or anxiety: 60 percent of 
the midwives’ patients were counseled about depression or anxiety, and 31 percent were referred 
to a mental health professional by the midwives. 
A collaborative relationship between midwives and a mindfulness-based cognitive 
therapist could also be formed, helping to enhance the mental health care depressed and/or 
anxious pregnant women receive. Midwives could inquire about current mood and mental state 
in their routine visits with women, and if a patient is experiencing symptoms during the visit, the 
midwife could do a brief mindfulness exercise recommended by the therapist with the patient. 
This additional, outside use and application of the mindfulness skills the patient is learning from 
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their therapist in treatment sessions would help to habituate the practice in the everyday lives of 
the patient.  
The analysis of the data also produced results not specifically intended as an aim of the 
study: the findings hold broader implications for midwifery practice. According to the responses 
of the midwives, a more formalized mindfulness-based training for future and current midwives 
may enhance the quality of the services they provide while simultaneously helping midwives to 
embody the spirit and philosophy of midwifery more fully. Cragin (2004) outlines three 
characteristics of the midwifery approach to care: 1.) the acknowledgement of a mind/body 
connection, 2.) honoring the woman’s perspective in relation to symptoms and care, and 3.) 
perceiving and preserving pregnancy and childbirth as a normal process, to only be interfered 
with unless absolutely necessary.  
Mindfulness was viewed by the midwives as almost an integral part of their role as a 
midwife, a foundation that would allow them to uphold the components of Cragin’s midwifery 
paradigm. Many midwives in the present study thought that mindfulness would help them to be 
with a woman during labor, to be present with her, and to be non-judgmentally aware of her 
perspective. Midwives also expressed the belief that mindfulness would help them to only 
intervene when truly necessary. Hence, an inherent relationship seems to exist between 
mindfulness and midwifery that should perhaps be given more dedicated, concentrated efforts to 
develop into a tangible union, rather than it remain a theoretical overture.  
Expanding and applying the results even broader, they also hold implications for clinical 
practice/adoption of mindfulness in general clinical practice. The midwives felt that adopting a 
mindfulness-based approach to one’s clinical practice would be conducive to better decision-
making and more efficient practice. The comment by one midwife about the effect using a 
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mindfulness-based approach has on appointment duration is most intriguing: by slowing down 
and being in the moment, appointment length actually decreases. Conducting shorter 
appointments during which optimal service is provided is perhaps the ultimate goal of clinical 
practice, especially considering the high rates of overburdened clinicians and increasing patient 
dissatisfaction with the interactions they have with their providers during office visits.  
Furthermore, the midwives’ thoughts that mindfulness would be a protective factor 
against burnout and increase patient satisfaction are congruent with the nascent empirical support 
for mindfulness-based interventions effectiveness in reducing clinician burnout. It should be 
noted that no studies have been done assessing the effectiveness of mindfulness-based 
interventions in reducing stress and burnout-related symptoms in the midwife population, despite 
the occurrence of burnout in the midwifery field (Beaver et al., 1986). 
Future quantitative studies of mindfulness in clinical settings could investigate clinical 
outcomes and patient satisfaction among clinicians—midwives included—who consistently and 
consciously apply mindfulness techniques and approaches to their clinical work. Replication of 
the positive findings from previous studies on mindfulness-based interventions and clinician 
burnout should be conducted as well. Empirical evidence for the conjectures pertaining to 
clinical outcomes is essential to adding credibility to mindfulness’s role in clinical settings. 
Revisiting the Diffusion of Innovations theory and framing the results within the 
components of the theory adds yet another dimension to the results. As mentioned previously, 
midwives were unanimously favorable to the idea of mindfulness and applying it to the clinical 
setting. Therefore, in a broader adoption of mindfulness, midwives do indeed occupy the role of 
Early Adopter, as predicted. However, when specifically asked about mindfulness-based 
interventions to use with their depressed and anxious patients, midwives seemed more skeptical 
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of this application of mindfulness in clinical practice. This reticence towards a more specified 
application of mindfulness aligns the midwives more with the Early Majority category. Future 
studies could delve deeper into this apparent uncertainty over using mindfulness-based 
interventions with pregnant women burdened with depression or anxiety.     
The barriers mentioned by the midwives could be explored further and then addressed by 
those who plan on launching implementation initiatives of mindfulness-based interventions in 
clinical settings. In terms of the barrier of acceptability of mindfulness, clinicians could be 
surveyed beforehand to elicit their existing views towards using mindfulness in clinical settings. 
If clinicians predominantly seem to oppose the use of mindfulness in clinical settings, this would 
be a good indicator that the implementation effort would probably not be successful. As such, 
time could be devoted prior to moving forward with the initiative to understand these skeptical 
attitudes, and possibly attempting to shift the views of mindfulness to one with a more positive 
tilt. If the skepticism seems particularly entrenched and resistant to change, then embarking upon 
a mindfulness-based intervention implementation effort would be better attempted elsewhere, at 
a different practice with different, more receptive professionals.  
The barrier relating to clinician lack of skill in practicing mindfulness could rather easily 
be countered with an intensive mindfulness training for clinicians to develop and bolster their 
skills; midwives themselves could attend a mindfulness-based stress reduction clinic. The 
benefits of attending the intensive training would be two-fold for the midwives: their 
mindfulness practitioner skills would improve and, indirectly, their clinical practitioner skills 
would improve. With their mindfulness skills enhanced, midwives would feel more confident in 
their ability to apply these skills to their clinical practice. This would also facilitate any 
accompanying implementation initiatives. 
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4.1 LIMITATIONS 
N 
Given the similarity between the philosophies of mindfulness and midwives, it is not surprising 
that midwives seemed very amenable to adopting mindfulness in the clinical setting. The very 
specialized population studied renders using the results to predict other clinicians’ and healthcare 
workers’ attitudes towards mindfulness in clinical settings difficult. The perspectives of a 
different population of clinicians in maternal and child health—and clinicians in other 
specialized areas of health service—should be obtained. Additionally, the small sample size 
compromises the salience of the themes that emerged from the data.  
Studying the topic of mindfulness is in and of itself a limitation: outlining a clear 
operational definition for mindfulness has been a challenging task for researchers (Rapgay & 
Bystrisky, 2009). Even though the midwives were given a scholarly article in a peer-reviewed 
journal that described mindfulness in clinical settings, it is difficult to discern whether or not 
each midwife had the same understanding of what mindfulness is; it is very likely that 
mindfulness could mean different things to different people, especially those not well versed in it 
or who have had minimal exposure to its philosophy and practices. However, it should be noted 
that the majority of midwives interviewed had an extensive to moderate knowledge of 
mindfulness prior to the study and reading the article. 
4.2 CONCLUSIO
Despite these limitations, the results yielded from this exploratory study are still pertinent to the 
literature on mindfulness as a complementary treatment modality for pregnant women suffering 
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from depression or anxiety. Any mindfulness-based interventions developed for alleviating 
symptoms of depression and anxiety in pregnant women may be best implemented by midwives. 
Furthermore, the findings may serve as an impetus to conducting future, more extensive and 
broadly-scoped studies of clinicians’ perspectives on using mindfulness-based interventions and 
a mindfulness approach to clinical work.  
Evidence is amassing in the literature that suggests mindfulness and mindfulness-based 
interventions impart numerous benefits when applied to the clinical setting. Clinicians and 
patients alike have been shown to enjoy the positive effects that mindfulness produces. In 
particular, a mindfulness-based intervention may be a promising non-invasive alternative for 
managing depression and anxiety in pregnant women. Having the support of those who would be 
administering the intervention is essential to successful adoption and implementation of 
mindfulness in clinical settings. The present study shows support among a particular subset of 
clinicians for using mindfulness in clinical settings and practice. 
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